Your browser doesn't support javascript.
loading
Antiviral Activity and Resistance Profile of the Novel HIV-1 Non-Catalytic Site Integrase Inhibitor JTP-0157602.
Ohata, Yoshitsugu; Tomonaga, Mitsunori; Watanabe, Yasuo; Tomura, Keiko; Kimura, Koji; Akaki, Tatsuo; Adachi, Kaoru; Kodama, Eiichi N; Matsuzaki, Yuji; Hayashi, Hironori.
Afiliación
  • Ohata Y; Department of Infectious Diseases, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
  • Tomonaga M; Central Pharmaceutical Research Institute, Japan Tobacco, Inc., Takatsuki, Osaka, Japan.
  • Watanabe Y; Central Pharmaceutical Research Institute, Japan Tobacco, Inc., Takatsuki, Osaka, Japan.
  • Tomura K; Central Pharmaceutical Research Institute, Japan Tobacco, Inc., Takatsuki, Osaka, Japan.
  • Kimura K; Central Pharmaceutical Research Institute, Japan Tobacco, Inc., Takatsuki, Osaka, Japan.
  • Akaki T; Central Pharmaceutical Research Institute, Japan Tobacco, Inc., Takatsuki, Osaka, Japan.
  • Adachi K; Central Pharmaceutical Research Institute, Japan Tobacco, Inc., Takatsuki, Osaka, Japan.
  • Kodama EN; Central Pharmaceutical Research Institute, Japan Tobacco, Inc., Takatsuki, Osaka, Japan.
  • Matsuzaki Y; Department of Infectious Diseases, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
  • Hayashi H; Division of Infectious Diseases, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.
J Virol ; 96(6): e0184321, 2022 03 23.
Article en En | MEDLINE | ID: mdl-35045265

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: VIH-1 / Inhibidores de Integrasa VIH / Integrasa de VIH Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: VIH-1 / Inhibidores de Integrasa VIH / Integrasa de VIH Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article